AR083399A1 - Proceso para la preparacion de cicloheptapiridina como antagonista del receptor de cgrp - Google Patents
Proceso para la preparacion de cicloheptapiridina como antagonista del receptor de cgrpInfo
- Publication number
- AR083399A1 AR083399A1 ARP110103778A ARP110103778A AR083399A1 AR 083399 A1 AR083399 A1 AR 083399A1 AR P110103778 A ARP110103778 A AR P110103778A AR P110103778 A ARP110103778 A AR P110103778A AR 083399 A1 AR083399 A1 AR 083399A1
- Authority
- AR
- Argentina
- Prior art keywords
- formula
- compound
- preparation
- salt
- group
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 238000002360 preparation method Methods 0.000 title abstract 3
- 108090000932 Calcitonin Gene-Related Peptide Proteins 0.000 title 1
- 102100025588 Calcitonin gene-related peptide 1 Human genes 0.000 title 1
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 6
- 150000003839 salts Chemical class 0.000 abstract 4
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- YQTCQNIPQMJNTI-UHFFFAOYSA-N 2,2-dimethylpropan-1-one Chemical group CC(C)(C)[C]=O YQTCQNIPQMJNTI-UHFFFAOYSA-N 0.000 abstract 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
- 125000004448 alkyl carbonyl group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000000460 chlorine Substances 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 230000008878 coupling Effects 0.000 abstract 1
- 238000010168 coupling process Methods 0.000 abstract 1
- 238000005859 coupling reaction Methods 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 238000010511 deprotection reaction Methods 0.000 abstract 1
- 125000004438 haloalkoxy group Chemical group 0.000 abstract 1
- 125000001188 haloalkyl group Chemical group 0.000 abstract 1
- 125000001475 halogen functional group Chemical group 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002883 imidazolyl group Chemical group 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- -1 phenoxy, substituted phenoxy , phenylthio Chemical group 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000003356 phenylsulfanyl group Chemical group [*]SC1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 abstract 1
- 125000000168 pyrrolyl group Chemical group 0.000 abstract 1
- 238000006268 reductive amination reaction Methods 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 125000004665 trialkylsilyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Pyrrole Compounds (AREA)
Abstract
Un proceso para la preparación de compuestos de la fórmula (1), que incluyen intermediarios de síntesis que son útiles en el proceso.Reivindicación 1: Un proceso para la preparación de un compuesto de la fórmula (1) o una sal de este, en donde Ar1 es fenilo sustituido por 0 - 3 sustituyentes seleccionados del grupo que consiste en ciano, halo, alquilo, haloalquilo, alcoxi, haloalcoxi y SO2-alquilo, caracterizado porque comprende la aminación reductora y la desprotección de alcohol de un compuesto de la fórmula (4) o una sal de este, en donde R1 se selecciona del grupo que consiste en trialquilsililo, alcoxi, alquilcarbonilo, bencilo, benzoilo y pivaloilo a un compuesto de la fórmula (2) o una sal de este, en donde R1 es hidrógeno; y el acoplamiento del compuesto de la fórmula (2) con un compuesto de la fórmula (3) o una sal de este, en donde R2 se selecciona del grupo que consiste en imidazolilo, pirrolilo, N-hidroxisuccinimidilo, cloro, fenoxi, fenoxi sustituido, feniltio y feniltio sustituido.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39218310P | 2010-10-12 | 2010-10-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR083399A1 true AR083399A1 (es) | 2013-02-21 |
Family
ID=44720182
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP110103778A AR083399A1 (es) | 2010-10-12 | 2011-10-12 | Proceso para la preparacion de cicloheptapiridina como antagonista del receptor de cgrp |
Country Status (4)
| Country | Link |
|---|---|
| US (5) | US8669368B2 (es) |
| AR (1) | AR083399A1 (es) |
| TW (1) | TW201219390A (es) |
| WO (1) | WO2012050764A1 (es) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2535074C2 (ru) | 2009-08-28 | 2014-12-10 | Лэйбрис Байолоджикс, Инк. | Способы лечения висцеральной боли путем введения антител-антагонистов, направленных против пептида, связанного с геном кальцитонина |
| US8669368B2 (en) | 2010-10-12 | 2014-03-11 | Bristol-Myers Squibb Company | Process for the preparation of cycloheptapyridine CGRP receptor antagonists |
| SI2820016T1 (sl) | 2012-02-27 | 2017-11-30 | Bristol-Myers Squibb Company | N-(5s,6s,9r)-5-amino-6-(2,3-difluorofenil)-6,7,8,9-tetrahidro-5h- ciklohepta (b)piridin-9-il-4-(2-okso-2, 3-dihidro-1h-imidazo(4,5-b) piridin-1-il) piperidin-1-karboksilat, hemisulfatna sol |
| RS65360B1 (sr) | 2014-03-21 | 2024-04-30 | Teva Pharmaceuticals Int Gmbh | Antagonistička antitela specifična za peptid genski srodan kalcitoninu i postupci njihove upotrebe |
| US10556945B2 (en) | 2014-03-21 | 2020-02-11 | Teva Pharmaceuticals International Gmbh | Antagonist antibodies directed against calcitonin gene-related peptide and methods using same |
| MX2019003337A (es) | 2016-09-23 | 2019-09-26 | Teva Pharmaceuticals Int Gmbh | Tratamiento para migraña refractaria. |
| AU2019242604A1 (en) | 2018-03-25 | 2020-10-22 | Pfizer Ireland Pharmaceuticals | Rimegepant for CGRP related disorders |
| JP2024505509A (ja) * | 2021-02-01 | 2024-02-06 | ファイザー アイルランド ファーマシューティカルズ | Ｃｇｒｐ阻害薬の医薬組成物およびそれらを使用する方法 |
| CN115850266A (zh) * | 2021-09-26 | 2023-03-28 | 奥锐特药业(天津)有限公司 | 瑞美吉泮新晶型及其制备方法 |
| CN116554164A (zh) * | 2022-01-27 | 2023-08-08 | 奥锐特药业(天津)有限公司 | 一种瑞美吉泮的制备方法 |
| CN116478211B (zh) * | 2022-04-19 | 2023-10-24 | 石家庄迪斯凯威医药科技有限公司 | 一种新型cgrp受体拮抗剂及其用途 |
| CN115677694A (zh) * | 2022-11-30 | 2023-02-03 | 南通常佑药业科技有限公司 | 一种瑞美吉泮的合成方法 |
| CN117486798A (zh) * | 2023-12-21 | 2024-02-02 | 南京威凯尔生物医药科技有限公司 | 一种瑞美吉泮中间体盐酸盐的晶型及其制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO2355B1 (en) | 2003-04-15 | 2006-12-12 | ميرك شارب اند دوم كوربوريشن | Hereditary calcitonin polypeptide receptor antagonists |
| US7947678B2 (en) * | 2005-07-29 | 2011-05-24 | Merck Sharp & Dohme Corp. | Heterocyclic benzodiazepine CGRP receptor antagonists |
| US20090176986A1 (en) | 2006-04-10 | 2009-07-09 | Mclaughlin Mark | Process for the Preparation of Pyridine Heterocycle Cgrp Antagonist Intermediate |
| ES2303776B1 (es) * | 2006-12-29 | 2009-08-07 | Laboratorios Almirall S.A. | Derivados de 5-fenil-6-piridin-4-il-1,3-dihidro-2h-imidazo(4,5-b)piridin-2-ona utiles como antagonistas del receptor de adenosina a2b. |
| US8044043B2 (en) * | 2008-04-11 | 2011-10-25 | Bristol-Myers Squibb Company | CGRP receptor antagonists |
| US8314117B2 (en) * | 2009-10-14 | 2012-11-20 | Bristol-Myers Squibb Company | CGRP receptor antagonists |
| US8669368B2 (en) | 2010-10-12 | 2014-03-11 | Bristol-Myers Squibb Company | Process for the preparation of cycloheptapyridine CGRP receptor antagonists |
-
2011
- 2011-09-19 US US13/236,072 patent/US8669368B2/en active Active
- 2011-09-21 WO PCT/US2011/052459 patent/WO2012050764A1/en active Application Filing
- 2011-10-12 AR ARP110103778A patent/AR083399A1/es not_active Application Discontinuation
- 2011-10-12 TW TW100137018A patent/TW201219390A/zh unknown
-
2014
- 2014-01-16 US US14/156,626 patent/US20140135500A1/en not_active Abandoned
- 2014-12-12 US US14/568,370 patent/US20150099887A1/en not_active Abandoned
-
2015
- 2015-08-24 US US14/833,891 patent/US20150361047A1/en not_active Abandoned
-
2016
- 2016-08-01 US US15/225,261 patent/US9718845B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20140135500A1 (en) | 2014-05-15 |
| US20160340373A1 (en) | 2016-11-24 |
| US9718845B2 (en) | 2017-08-01 |
| WO2012050764A1 (en) | 2012-04-19 |
| TW201219390A (en) | 2012-05-16 |
| US8669368B2 (en) | 2014-03-11 |
| US20150361047A1 (en) | 2015-12-17 |
| US20120245356A1 (en) | 2012-09-27 |
| US20150099887A1 (en) | 2015-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR083399A1 (es) | Proceso para la preparacion de cicloheptapiridina como antagonista del receptor de cgrp | |
| AR111813A2 (es) | Compuestos y composiciones para el control de nematodos | |
| AR072952A1 (es) | Compuestos de 2-imino-3-metilpirrolopirimidinona fenilo-sustituida como inhibidores de bace-1, composiciones y su uso | |
| TN2011000279A1 (en) | Novel pyrazole -4-n-alkoxycarboxamides as microbiocides | |
| HRP20090235A2 (en) | Carbonylated (aza) cyclohexanes as dopamine d3 receptor ligands | |
| CU20110052A7 (es) | Compuestos orgánicos | |
| AR055779A1 (es) | Proceso de preparacion de azoxistrobina y composicion que contiene al compuesto | |
| PH12013500365A1 (en) | Anti-infective agents and uses thereof | |
| IN2014CN01136A (es) | ||
| TW200720366A (en) | Process for preparing metal compounds of an azo compound in the presence of seed crystals | |
| MA35245B1 (fr) | Pyridin-2-amides utiles comme agonistes de cb2 | |
| EA201070912A1 (ru) | Производные оксима в качестве ингибиторов hsp90 | |
| DOP2011000123A (es) | Nuevos compuestos halosustituidos | |
| AR093184A1 (es) | Compuesto de pirimidina sustituida como inhibidor de quinurenina-3-monooxigenasa y composicion farmaceutica que lo comprenden | |
| AR079662A1 (es) | Indolil-piperidinil bencilaminas como inhibidores de beta-triptasa | |
| AR079748A1 (es) | Arilpirrolidinas plaguicidas | |
| CY1112829T1 (el) | Νεα μεθοδος συνθεσης για την αγομελατινη | |
| UA102289C2 (ru) | Гербициды, полученные из циклопентадиона | |
| EA201170282A1 (ru) | Фунгицидные n-циколоалкил-n-бифенилметилкарбоксамидные производные | |
| MY152281A (en) | 4-pyrimidinesulfamide derivative | |
| NI201000049A (es) | Método para producir 2'-desoxi-5-azacitidina (decitabina) | |
| MX337320B (es) | Análogos halogenados de agentes anti-fibroticos. | |
| AR072803A1 (es) | Tetrahidrocinolinas como inhibidores de la 11- beta -hsd1 para la diabetes | |
| NI201100093A (es) | 1-(arilsulfonil)-4-(piperazin-1-il)-1h-benzimidazoles como ligandos de 5-hidroxitriptamina-6. | |
| CR11071A (es) | Pirimidinil-piperazinas utiles como ligandos del receptor d3/d2 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |